GeneGlobe ID: PHS-203Z | Cat. No.: | QIAseq Targeted DNA Pro Panels

QIAseq Targeted DNA Pro Human Hematologic Malignancy Panel

Kit containing ALL reagents (except indexes) for targeted DNA sequencing

Select a variant to see the price

Product Specification

Target List

Eosinophilia
CR2, JAK1
Lymphoproliferative Disorders
PLAA, SH2D1A, XIAP
Mastocytosis
DNMT3A, IDH2, KIT (CD117), NRAS, RUNX1 (AML1)
Multiple Myeloma
ATM, CCND1, IDH1, IDH2, KIT (CD117), LIG4, NRAS, TP53 (p53)
Myelodysplastic Syndromes
CEBPA, DNMT3A, GATA2, GNB1, IDH1, IDH2, KIT (CD117), MPL, MSH6, NF1, NRAS, RUNX1 (AML1), SMAD9, TERC, TERT, TP53 (p53)
Myelofibrosis
DNMT3A, IDH1, IDH2, MPL, NF1, NRAS, TP53 (p53)
Myeloproliferative Neoplasms
DNMT3A, IDH1, IDH2, MPL, RUNX1 (AML1), SH2B3, TP53 (p53)
Polycythemia Vera
DNMT3A, IDH1, NRAS, TP53 (p53)
Thrombocythemia
IDH2, MPL, SH2B3, THPO, TP53 (p53)
Other Hematological Malignancies Genes
BLM, EPCAM, HRAS, MLH1, MSH2, NBN, PMS2

Resources

Application Notes (1)
Kit Handbooks (2)
For ultrasensitive targeted next-generation sequencing of DNA for Ion Torrent NGS systems
For ultrasensitive targeted next-generation sequencing (NGS) of DNA for Illumina NGS systems
Safety Data Sheets (1)
Certificates of Analysis (1)
Template Files (1)
icon_0071_person-s

Do you want to create a custom panel or to boost an existing one?

 

Introducing the QIAseq Targeted DNA Pro Human Hematologic Malignancy Panel, a cutting-edge addition to our QIAseq Targeted DNA Pro Panels lineup, specifically designed for NGS applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the QIAseq Targeted DNA Pro Human Hematologic Malignancy Panel facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting NGS, or any other sophisticated analyses, this product from our QIAseq Targeted DNA Pro Panels collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with QIAseq Targeted DNA Pro Human Hematologic Malignancy Panel and elevate your work to new heights.